FHAD1-AS1

Across TCGA pan-cancer cohorts, FHAD1-AS1 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of FHAD1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where FHAD1-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FHAD1-AS1 is over-expressed in tumor, although a few such as KICH and KIRC show the opposite, repressed pattern.

HNSC, KICH, and KIRC are the cancer types where FHAD1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FHAD1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	+0.035	<.001	12	view →
KICH	Male	All	−0.324	<.001	10	view →
KIRC	All	All	−0.120	<.001	10	view →
KIRP	All	All	−0.125	<.001	9	view →
COAD	All	All	−0.061	.003	5	view →
READ	All	All	−0.200	.010	4	view →
THCA	Male	II,III,IV	−0.856	<.001	3	view →
PRAD	All	All	−0.483	<.001	2	view →
BLCA	Male	All	−0.153	.009	2	view →
CHOL	All	All	+0.027	.009	2	view →
STAD	All	All	−0.110	.038	1	view →
BRCA	Female	All	−0.013	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

FHAD1-AS1–HNSC

Open the HNSC breakdown →